Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by palinc2000on Jul 14, 2022 1:46pm
231 Views
Post# 34824721

Transparency in today s PR 's and CC

Transparency in today s PR 's and CC In general I am very pleased with today s PR s and CC
Maybe some would have liked more hype to get a better market response but IMO the big bang will come  if and when a big pharma  knocks on the door and rather quickly enters into a collaboration agreement...That would beat anything the company can say or do at this stage...It is incorrect  to think  that big pharmas  will not be aware of today s update....I think THTX will have to hire an assistant just to book appointments ,,,,,,or maybe that would be the Chief  of Staff s
Very short term -China 
Few  wqeeks /months -----Big Pharma /Biotech

Of course we would all love a  much higher SP especially after the meltdown in the broader markets but that would require mgmt to make public  statements that go much beyond what they can prove atm ....However when talking to big pharmas they can hype much more because they are dealing with sophisticated  people....
Today is a good day !not only for oncology news but also to see the depth of mgmt. and the potential in other areas ..We are in good hands with Allstate ....I mean with THTX!!!



<< Previous
Bullboard Posts
Next >>